| |
| |
|
| Insider
Information: |
Clark Mitchall G. |
| Relationship: |
EVP & Chief R & QA Off... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
107,972 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$74,501 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
107,972 |
|
|
| Total
Value |
$74,501 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
EVP & Chief R & QA Off... |
2018-05-18 |
107,972 |
2015-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-05-18 |
4 |
AS |
$50.03 |
$1,293,776 |
D/D |
(25,860) |
107,972 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-05-16 |
4 |
AS |
$46.04 |
$214,026 |
D/D |
(4,647) |
133,832 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,808 |
138,479 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-03-29 |
4 |
AS |
$40.07 |
$897,568 |
D/D |
(22,400) |
133,671 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-03-27 |
4 |
AS |
$36.43 |
$3,795,062 |
D/D |
(100,203) |
156,071 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-03-27 |
4 |
OE |
$11.00 |
$1,589,393 |
D/D |
72,754 |
256,274 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-02-15 |
4 |
D |
$47.05 |
$169,568 |
D/D |
(3,604) |
183,520 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,211 |
187,124 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-02-09 |
4 |
D |
$41.70 |
$154,457 |
D/D |
(3,704) |
179,913 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-02-06 |
4 |
D |
$35.80 |
$158,845 |
D/D |
(4,437) |
183,617 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
188,054 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-11-16 |
4 |
AS |
$14.20 |
$46,718 |
D/D |
(3,290) |
163,052 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,212 |
166,342 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-08-16 |
4 |
AS |
$14.33 |
$43,291 |
D/D |
(3,021) |
159,130 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,211 |
162,151 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-05-16 |
4 |
AS |
$15.25 |
$59,063 |
D/D |
(3,873) |
153,000 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,212 |
156,873 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-02-16 |
4 |
AS |
$15.96 |
$48,822 |
D/D |
(3,059) |
149,661 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
EVP & Chief R & QA Officer |
• – – |
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,211 |
152,720 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief R & QA Officer |
• – – |
2016-11-16 |
4 |
AS |
$19.53 |
$58,492 |
D/D |
(2,995) |
95,187 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief R & QA Officer |
• – – |
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,212 |
98,182 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief R & QA Officer |
• – – |
2016-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,211 |
90,970 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief R & QA Officer |
• – – |
2016-05-16 |
4 |
AS |
$15.15 |
$62,918 |
D/D |
(4,153) |
83,759 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief R & QA Officer |
• – – |
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,212 |
87,912 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief R & QA Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,211 |
84,853 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
